House May Be Stopping Point For Rx Importation Bills, Hill Staffer Says
Executive Summary
The House could be the last line of defense for blocking prescription drug importation legislation, rather than the Senate, a House subcommittee staffer said Nov. 17 at the Pharmaceutical Regulatory & Compliance Congress in Washington, D.C